Ms. Natalia S. Usoltseva, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3823 - 172nd St Ne, Cascade Skagit Health Alliance, Arlington, WA 98223 Phone: 360-618-5000 Fax: 360-659-9834 |
Dr. Sally Ann Newbrough, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4011 172nd St Ne, Arlington, WA 98223 Phone: 425-339-5412 Fax: 360-363-4750 |
Dr. Patrycja A. Turek, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3823 - 172nd St Ne, Cascade Skagit Health Alliance, Arlington, WA 98223 Phone: 360-651-8365 Fax: 360-651-8368 |
Dr. Steven English, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2901 174th Pl Ne, Arlington, WA 98223 Phone: 360-454-1900 |
William H Coyne, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 S Stillaguamish Ave, Arlington, WA 98223 Phone: 360-435-2133 Fax: 360-435-0513 |
News Archive
Advances in genetic testing offer new insights to parents who have a child with a rare but serious form of epilepsy, epileptic encephalopathy (EE), found in one of about every 2,000 births and characterized by developmental disabilities as well as horrible seizures.
Brain images of children with dyslexia taken before they received spelling instruction show that they have different patterns of neural activity than do good spellers when doing language tasks related to spelling. But after specialized treatment emphasizing the letters in words, they showed similar patterns of brain activity.
If I may, as a former HHS secretary, offer a suggestion to the current secretary, it would be this: Use these expanded discretionary powers to grant states and the private sector more flexibility and more autonomy.
Scientists investigating the cough reflex have discovered a new group of molecules on the surface of nerve cells that make us cough when irritated.
Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.
› Verified 7 days ago